5195 Results
Guidelines and Advice
Status: Current
ID: GL 20-2
Version: 2
ID: GL 20-2
Version: 2

Updated
Apr 2025
Drug
Jan 2025
A variety of screening tools and resources are available to support the screening activities of primary care providers, nurses and specialists.
Guidelines and Advice
Status: In-Review
ID: 16-4
ID: 16-4
May 2015
Guidelines and Advice
Status: In-Review
ID: 26-4
ID: 26-4
Jun 2015
Guidelines and Advice
Drug
Other Name(s): Rituxan®
, Truxima™
, Riximyo™
, Ruxience™
, Riabni™
Apr 2025
Cancer Care Ontario monitors and publicly reports on cancer incidence (new cases) and mortality (deaths) over time by place (e.g., Local Health...
Statistical Reports
Jun 2016